TOP NEWS: GSK's raised outlook clouded by weak vaccines, Shingrix drop
(Alliance News) - GSK PLC on Wednesday raised its annual guidance after a strong second quarter but shares fell on a lowered outlook for its Vaccines arm and disappointing Shingrix sales. Read More